Retail Clinics

  • Medco: Poor adherence may cause lack of response to medication

    BOSTON When a patient isn’t showing a response to a medication, a common tactic the doctor might use is to increase the dosage. According to a new study, however, the ineffectiveness might be happening because the patient isn’t properly taking the medication.

  • Study: Mediterranean diet may cut diabetes risk

    REUS, Spain New research has found a Mediterranean diet can cut the risk of developing Type 2 diabetes by 50% in nondiabetics with high cardiovascular risk.

    The study was conducted by Jordi Salas-Salvado and colleagues and published online in the Oct. 7 edition of Diabetes Care. This is the first randomized clinical trial to look specifically at use of the Mediterranean diet for the prevention of diabetes, the investigators said.

  • Anthem Blue Cross recognized for its diabetes pilot program

    WOODLAND HILLS, Calif. A local Blue Cross chapter has gained national recognition for its pilot diabetes program.

    Anthem Blue Cross' health equities pilot is 1-of-7 programs recognized this year with a Best of Blue Clinical Distinction Award, an award developed by the Blue Cross Blue Shield Association and the Harvard Medical School department of healthcare policy, Anthem Blue Cross said.

  • Watson's generic Lotrel gets FDA approval

    MORRISTOWN, N.J. The Food and Drug Administration has approved a Watson Pharmaceuticals generic drug for treating high blood pressure, Watson said Friday.

     

    The company announced the FDA approval of amlodipine besylate and benazepril capsules in the 5/20-mg, 10/20-mg, 2.5/10-mg and 5/10-mg strengths.

     

     

    The drug is a generic version of Novartis’ Lotrel. Branded and generic versions of the drug had sales of around $1.05 billion during the 12-month period ended in June, according to IMS Health.

     

  • Diabetes-related hospitalizations on the rise, study finds

    NEW YORK More young adults, particularly young women, are being hospitalized for diabetes-related issues, according to a new study.

    The study — published online in the Oct. 12 edition of Journal of Women's Health, led by Joyce Lee of the University of Michigan in Ann Arbor and colleagues — evaluated hospital discharges with a primary or secondary diagnosis of diabetes from the Nationwide Inpatient Sample between 1993 and 2006.

  • Mylan's Hyzaar, Cozaar generics receive OK from FDA

    PITTSBURGH The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension, Mylan said Friday.

     

    The company announced the approval of losartan potassium and hydrochlorothiazide tablets in the 50/12.5-mg and 100/25-mg strengths, and losartan potassium tablets in the 25-mg, 50-mg and 100-mg strengths, generic versions of Merck’s Hyzaar and Cozaar, respectively. Mylan began marketing its version of Hyzaar in the 100/12.5-mg strength in April.

     

     

  • Identigene introduces STD test kit

    SALT LAKE CITY Identigene on Thursday officially unveiled its Identigene STD test kit, which currently is available over the counter at Rite Aid.

    Purchasers of the Identigene STD test kit can receive a highly accurate test result for chlamydia and gonorrhea, two of the more popular sexually transmitted diseases, within two to three business days of receipt of a urine specimen by the Identigene laboratory.

  • Insurers ease pharmacy vaccine process

    MOUNTLAKE TERRACE, Wash., and PORTLAND, Ore. Two health insurers in the northwest are taking steps to change the dynamics of preventive health reimbursement and broaden the role pharmacies play in flu vaccination efforts.

     

    The two plans, Premera Blue Cross of Washington state and LifeWise Health Plan of Oregon, have announced new programs that both plans said will “remove barriers to care by providing improved access to common immunizations at pharmacies.”

     

     

  • NACDS Foundation supports new NEHI report on care teams, medication adherence

    ALEXANDRIA, Va. A report by the New England Healthcare Institute that addressed the role of care teams in improving medication adherence among patients has received support from the charitable arm of the National Association of Chain Drug Stores.

  • A&D Medical rolls out new monitoring devices

    SAN JOSE, Calif. A&D Medical on Wednesday introduced three new wireless telehealth and wellness devices featuring ANT technology.

     

    A&D Medical's monitoring devices with ANT wireless technology are essential feedback components for wellness coaching and health tracking, the company stated. Suitable for Web-based employee health programs, disease management, prevention programs and consumer wellness solutions, A&D Medical's ANT devices enable a richer, more data-driven experience for both program administrators and end users.

     

X
This ad will auto-close in 10 seconds